Rapid Micro Biosystems (RPID) Operating Expenses (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Operating Expenses data on file, last reported at $14.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 17.89% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2026 stood at $76.3 million (up 8.82% YoY), and the FY2025 full-year result was $81.0 million, up 3.86% from the prior year.
• Operating Expenses slipped to $14.2 million in Q1 2026, from $23.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $23.5 million in Q4 2025 to a low of $12.1 million in Q1 2025.
• A 5-year average of $19.2 million and a median of $19.6 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses surged 30.46% in 2022 and slumped 39.32% in 2025, its largest moves.
• Tracing RPID's Operating Expenses over 5 years: stood at $21.6 million in 2022, then slipped by 14.37% to $18.5 million in 2023, then fell by 0.42% to $18.4 million in 2024, then gained by 27.35% to $23.5 million in 2025, then sank by 39.46% to $14.2 million in 2026.
• Business Quant data shows RPID's Operating Expenses at $14.2 million in Q1 2026, $23.5 million in Q4 2025, and $19.2 million in Q3 2025.